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OBJECTIVES
1. Summarize details of unique case involving undiagnosed clotting disorder in a
collegiate athlete.
2. Present overview regarding mechanism and epidemiology of protein S
deficiency.
3. Identify the role of the certified athletic trainer in the evaluation and treatment
process, and as a patient advocate.
4. Emphasize importance of trust and communication between athlete, certified
athletic trainer, and team physician throughout evaluation and treatment.
CONCLUSIONS
The ACL injury and subsequent repair served as two traumatic events, triggering
initial and secondary DVT and PE. Presence of blood thinners appears to have
initially prevented accurate diagnosis. Athlete continues rehabilitation with AT
status-post ACL repair. There are no activity restrictions at this time. However,
physician recommendations include delayed return to athletic competition due to
complications in post-op ACL rehab and long-term prophylactic use of blood
thinners.
Athletic trainers should be aware of signs and symptoms of DVT and PE and
advocate for additional diagnostics in the best interest of their patient if warranted.
Clearance for athletic participation does not guarantee absence of medical
conditions that may result in life-threatening situations. Screening for clotting
disorders is not common practice and athletes may be unaware of inherited
clotting disorders.
PROTEIN S DEFICIENCY
Protein S acts to regulate chemical reactions in blood to prevent disproportionate
clotting. Deficiency of this protein occurs in two forms – either a decrease in level
or overall function.1,2 This is often hereditary, but may occur secondary to vitamin
K deficiency or liver disease.1,2 Limited data suggest deficiency occurs in less than
2% of the general population with a higher occurrence rate in individuals of Asian
descent.1,3 Although the occurrence of a DVT is rarely caused by sport-related
trauma, the presence of a clotting disorder such as protein S deficiency increases
the risk of occurrence from both sport-related soft-tissue trauma and surgical
procedures.1
https://www.xpertdox.com/disease-description/Protein%20S%20Deficiency
Figure 1.  Protein S Deficiency  
CITATIONS
1. Grabowski, G, Whiteside, WK, Kanwisher, M.  Venous Thrombosis in Athletes.  
J Am Acad Orthop Surg.  2013;21:  108-117.  http://dx.doi.org/10.5435/JAAOS-
21-02-108
2. D’Angelo, A, D’Angelo, SV. Protein S Deficiency. Haematol. 2008; 93(4), 498-
501.
3. Protein S Deficiency.  Medscape web site.   
https://emedicine.Medscape.com/article/205582-overview#a6.
Published August 5, 2017. Accessed 11/1/2017.
HISTORY OF PRESENT ILLNESS
A 19-year old Chinese-American track and field athlete presented to certified
athletic trainer (AT) in March 2016 with antalgic gait related to pain and edema in
left calf two weeks post-injury ACL injury. Initial injury occurred during pole
vault practice. Evaluation of initial knee injury by AT occurred on the day of
injury and referral to team physician took place three days post-injury. MRI
confirmed complete tear of ACL. Rehabilitation began immediately and surgery
was scheduled. Two weeks post-injury, athlete presented with swelling, redness,
warmth and tenderness to palpation of left calf and positive Homan’s sign. Athlete
reported onset of symptoms over period of prior three days and complained of
intermittent shortness of breath with ADL.
DIFFERENTIAL DIGANOSIS: DVT, superficial thrombophlebitis,
gastrocnemius strain, ruptured popliteal cyst.
Concerns related to a DVT resulted in consultation with team physician and
subsequent referral to emergency department (ED). Initial ultrasound (US) was
negative and athlete was sent home. Symptoms persisted and worsened over next
week and follow-up ED referral occurred following AT advocating for repeat test
with team physician. Second US was positive for a DVT. Athlete was given
Lovenox injection and Warfarin Rx and sent home. Symptoms worsened over next
three days and athlete was admitted to hospital after AT consultation with athlete’s
family doctor led to third ED visit. Additional testing confirmed DVT and
identified multiple pulmonary emboli (PE), resulting in venous thromboembolism
diagnosis. (Figure 1) Athlete was hospitalized five days for treatment and
monitoring. Remaining treatment details available in Figure 2.
Prior to start of season, athlete received clearance for full physical activity. No
pertinent personal or family history reported. Athlete’s medical history did not
include any major soft-tissue trauma, surgery or hereditary clotting disorders.
DOI and initial evaluation
• MOI:  Pole vault practice, hyperextension of plant leg
DOI + 1 day
• Began post-injury treatment protocol (partial weight-bearing, RICE, 
AROM)
DOI + 3 days
• Evaluation by team physician
DOI + 10 days
• 1st MRI (+) complete ACL tear, surgery scheduled
DOI + 14 days
• Athlete reports onset of new symptoms 3 days prior
• Referred to ED for DVT symptoms, US (-)
• Sent home w/ recommendation to continue rehabilitation and monitor
DOI + 20 days
• Symptoms worsen  2nd referral for DVT symptoms
• US (+) for DVT
• Lovenox injection and Rx for Warfarin
DOI + 23 days
• Dx w/ DVT + PE = VTE
• Admitted to hospital for 1 week
• ACL surgery canceled
• Warfarin x 2 weeks, Pradaxa x 6 months
DOI + 240 days
• ACL repair after 3 follow-up US (-)
• Dx tests for clotting disorders repeatedly (-), clot almost fully resolved
• Xarelto post-operatively
DOI + 247 days
• Recurrence of DVT and PE
• Hospitalized for 1 week
DOI + 277 days
• Dx w/ protein-S deficiency 
• Unmasked by athlete discontinuing Rx against physician recommendation
• Began prophylactic treatment with Lovenox Xarelto
• Rehabilitation continues 1+ years post-op w/ goal of return to recreational 
activity
Figure 2.  Treatment Timeline
http://www.daiichisankyo.com.hk/DiseaseInformation/VenousThromboembolism
Figure 1.  Venous Thromboembolism (VTE)
